article thumbnail

Janssen leads effort to cut waste in digital health devices

pharmaphorum

.” The programme has been set up to develop four devices – an e-paper label, smart wearable sensor, smart pill box, and endo-cutter used in surgical procedures – with funding from the EU’s Horizon Europe programme and support from the Waste Electrical and Electronic Equipment (WEEE) Forum.

Leads 114
article thumbnail

Data-Driven Connections: Linking Rare Disease Patients to Clinical Trials, Experts, and Resources

PM360

Simply put, identifying a disorder and receiving a formal diagnosis is at the root of myriad difficulties—from connecting a patient to a community to generating an appropriate care and treatment plan that ideally goes beyond managing symptoms to connecting a patient to clinical trials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. One of the biggest challenges is ensuring that patient privacy is protected.

article thumbnail

Evolution of ePROM: Advancements, Concerns, and the Way Forward

PM360

Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for understanding the disease’s natural history, palliative treatments that focus primarily on symptom control, and quality of life. 2 For example, in a study by Scripps, ePROMs positively impacted patients’ quality of life in 61.5%

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. One of the biggest challenges is ensuring that patient privacy is protected.

article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

The rule applies to developers of Certified Electronic Health Record Technology (CEHRT), particularly those who incorporate predictive decision support interventions (DSIs) into their products. Effective: Ensures that DSIs achieve their intended outcomes, improving clinical decision-making and patient care.

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

If data used to support the safety , efficacy and quality of pharmaceutical products is compromised or unreliable, it can lead to regulatory non-compliance, product recalls, and most importantly, harm to patients who depend on those medications. Ethical leadership is essential in promoting a culture of integrity within an organisation.